Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Precision Diagnosis and Treatment of High-grade Serous Ovarian Carcinoma During the Perioperative Period Assisted by Multi-omics and Artificial Intelligence Models, and Research on the Heterogeneity of Immune Microenvironment

NCT07721675 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.

NCT NCT07721675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07721675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Precision Diagnosis and Treatment of High-grade Serous Ovarian Carcinoma During the Perioperative Period Assisted by Multi-omics and Artificial Intelligence Models, and Research on the Heterogeneity of Immune Microenvironment
Lead sponsor
The Affiliated Hospital of Qingdao University
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
December 31, 2027
Enrollment
1,300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade serous ovarian carcinoma (hgsoc)